Published in Arch Intern Med on July 01, 1974
Bacteremia due to Bifidobacterium, Eubacterium or Lactobacillus; twenty-one cases and review of the literature. Yale J Biol Med (1979) 1.44
Effect of clindamycin and lincomycin therapy on faecal flora. J Clin Pathol (1978) 0.85
Clindamycin in treatment of aspiration pneumonia in children. Antimicrob Agents Chemother (1979) 0.82
Acute pelvic inflammatory disease and clinical response to parenteral doxycycline. Antimicrob Agents Chemother (1975) 0.75
Comparison of ampicillin with clindamycin plus gentamicin in the treatment of postpartum uterine infection. Can Med Assoc J (1979) 0.75
The therapy of anaerobic infections in obstetrics and gynecology. Infection (1980) 0.75
Antibiotic-associated pseudomembranous colitis due to toxin-producing clostridia. N Engl J Med (1978) 14.65
Plasmid-controlled colonization factor associated with virulence in Esherichia coli enterotoxigenic for humans. Infect Immun (1975) 14.65
Production of vascular permeability factor by enterotoxigenic Escherichia coli isolated from man. Infect Immun (1973) 9.99
Susceptibility of anaerobes to cefoxitin and other cephalosporins. Antimicrob Agents Chemother (1975) 8.86
In vitro activity of thienamycin. Antimicrob Agents Chemother (1978) 8.76
Anaerobic infections. 1. N Engl J Med (1974) 8.02
Enterotoxigenic Escherichia coli isolated from patients with severe cholera-like disease. J Infect Dis (1971) 7.10
In vitro activity of LY127935. Antimicrob Agents Chemother (1979) 7.01
Acute undifferentiated human diarrhea in the tropics. I. Alterations in intestinal micrflora. J Clin Invest (1971) 6.23
Toxigenic Escherichia coli: a cause of infantile diarrhea in Chicago. N Engl J Med (1972) 5.45
Treating diarrhoea. BMJ (1997) 5.22
Travelers' diarrhea and toxigenic Escherichia coli. N Engl J Med (1975) 5.20
Polymyxin B-Induced Release of Low-Molecular-Weight, Heat-Labile Enterotoxin from Escherichia coli. Infect Immun (1974) 4.79
Identification of enterotoxigenic Escherichia coli and serum antitoxin activity by the vascular permeability factor assay. Infect Immun (1973) 4.07
Clindamycin-induced enterocolitis in hamsters as a model of pseudomembranous colitis in patients. Infect Immun (1978) 3.93
Experimental intra-abdominal abscesses in rats: development of an experimental model. Infect Immun (1974) 3.91
In vitro activity of N-formimidoyl thienamycin (MK0787). Antimicrob Agents Chemother (1980) 3.90
Intestinal microflora. Gastroenterology (1971) 3.86
Intestinal flora in health and disease. Gastroenterology (1984) 3.84
Susceptibility of the Bacteroides fragilis group in the United States in 1981. Antimicrob Agents Chemother (1983) 3.83
Studies of intestinal microflora. II. Microorganisms of the small intestine and their relations to oral and fecal flora. Gastroenterology (1967) 3.71
Management of anaerobic infections. Ann Intern Med (1975) 3.62
Studies of intestinal microflora. I. Effects of diet, age, and periodic sampling on numbers of fecal microorganisms in man. Gastroenterology (1967) 3.60
Rapid diagnosis of anaerobic infections by direct gas-liquid chromatography of clinical speciments. J Clin Invest (1976) 3.34
Microbial synergy in experimental intra-abdominal abscess. Infect Immun (1976) 3.21
Abdominal trauma, anaerobes, and antibiotics. Surg Gynecol Obstet (1973) 3.18
Anaerobic infections (second of three parts). N Engl J Med (1974) 3.18
Anaerobic infections (third of three parts). N Engl J Med (1974) 3.13
Intestinal fluid and electrolyte transport in human cholera. J Clin Invest (1970) 3.09
Studies on enterotoxin from Escherichia coli associated with acute diarrhea in man. J Lab Clin Med (1971) 3.03
Survival of Lactobacillus species (strain GG) in human gastrointestinal tract. Dig Dis Sci (1992) 2.78
Inactivation of cephalosporins by Bacteroides. Antimicrob Agents Chemother (1979) 2.75
Pseudomembranous enterocolitis (antibiotic-related colitis). Adv Intern Med (1977) 2.73
In vitro activity of ticarcillin against anaerobic bacteria compared with that of carbenicillin and penicillin. Antimicrob Agents Chemother (1977) 2.71
Antimicrobial susceptibilities of 1,292 isolates of the Bacteroides fragilis group in the United States: comparison of 1981 with 1982. Antimicrob Agents Chemother (1984) 2.71
Hormone levels during dietary changes in premenopausal African-American women. J Natl Cancer Inst (1996) 2.59
Effect of preoperative neomycin-erythromycin intestinal preparation on the incidence of infectious complications following colon surgery. Ann Surg (1973) 2.57
Antimicrobial therapy of experimental intraabdominal sepsis. J Infect Dis (1975) 2.56
Stimulation of intestinal adenyl cyclase by Escherichia coli enterotoxin: comparison of strains from an infant and an adult with diarrhea. J Infect Dis (1974) 2.52
Nationwide study of the susceptibility of the Bacteroides fragilis group in the United States. Antimicrob Agents Chemother (1985) 2.47
Neutralization of Clostridium difficile toxin by Clostridium sordellii antitoxins. Infect Immun (1978) 2.39
Plasmid-mediated, transferable resistance to clindamycin and erythromycin in Bacteroides fragilis. J Infect Dis (1979) 2.38
Preoperative oral antibiotics reduce septic complications of colon operations: results of prospective, randomized, double-blind clinical study. Ann Surg (1977) 2.36
Experimental intra-abdominal abscesses in rats: quantitative bacteriology of infected animals. Infect Immun (1974) 2.33
Rapid microbiological assay for chloramphenicol and tetracyclines. Antimicrob Agents Chemother (1976) 2.26
Antimicrobial substance from a human Lactobacillus strain. Antimicrob Agents Chemother (1987) 2.25
Acute undifferentiated human diarrhea in the tropics. II. Alterations in intestinal fluid and electrolyte movements. J Clin Invest (1971) 2.22
Survival of lactic acid bacteria in the human stomach and adhesion to intestinal cells. J Dairy Sci (1987) 2.17
Anaerobic infections of the female genital tract: bacteriologic and therapeutic aspects. Am J Obstet Gynecol (1973) 2.07
The human intestinal microflora. Dig Dis Sci (1986) 2.07
Bacteriology of empyema. Lancet (1974) 2.00
National survey on the susceptibility of Bacteroides fragilis group: report and analysis of trends in the United States from 1997 to 2004. Antimicrob Agents Chemother (2007) 1.95
Efficacy of preoperative antimicrobial preparation of the bowel. Ann Surg (1972) 1.88
Successful treatment of relapsing Clostridium difficile colitis with Lactobacillus GG. Lancet (1987) 1.88
Purification of Shigella dysenteriae 1 (Shiga)-like toxin from Escherichia coli O157:H7 strain associated with haemorrhagic colitis. Lancet (1983) 1.87
Anaerobes survive in clinical specimens despite delayed processing. J Clin Microbiol (1976) 1.87
Estrogen metabolism and excretion in Oriental and Caucasian women. J Natl Cancer Inst (1994) 1.85
Antimicrobial use in animal feed--time to stop. N Engl J Med (2001) 1.84
Attachment pili from enterotoxigenic Escherichia coli pathogenic for humans. Infect Immun (1979) 1.80
Studies of intestinal microflora. V. Fecal microbial ecology in ulcerative colitis and regional enteritis: relationship to severity of disease and chemotherapy. Gastroenterology (1968) 1.80
Anaerobic microflora of the cervix in healthy women. Am J Obstet Gynecol (1973) 1.78
Estrogen excretion patterns and plasma levels in vegetarian and omnivorous women. N Engl J Med (1982) 1.77
Studies of intestinal microflora. IV. The microflora of ileostomy effluent: a unique microbial ecology. Gastroenterology (1967) 1.76
Weight loss and wasting remain common complications in individuals infected with human immunodeficiency virus in the era of highly active antiretroviral therapy. Clin Infect Dis (2000) 1.74
Bacteria, bile, and the small bowel. Gut (1969) 1.74
Aerobic and anaerobic bacteria in diabetic foot ulcers. Ann Intern Med (1976) 1.73
Soybean phytoestrogen intake and cancer risk. J Nutr (1995) 1.72
Serotypes of attachment pili of enterotoxigenic Escherichia coli isolated from humans. Infect Immun (1981) 1.72
Superoxide dismutase in anaerobic bacteria of clinical significance. Infect Immun (1977) 1.68
Candida infections in surgical patients. Ann Surg (1983) 1.63
Acute diarrhea--a "toxin" disease? N Engl J Med (1970) 1.63
Effect of dissolved oxygen and Eh and Bacteroides fragilis during continuous culture. Appl Environ Microbiol (1976) 1.62
The microflora of the human ileum and intrabdominal colon: results of direct needle aspiration at surgery and evaluation of the technique. J Lab Clin Med (1972) 1.61
Hemagglutination and adhesiveness of toxigenic Escherichia coli isolated from humans. Infect Immun (1979) 1.60
Rapid identification of Clostridium difficile by toxin detection. J Clin Microbiol (1982) 1.59
Oral (n-3) fatty acid supplementation suppresses cytokine production and lymphocyte proliferation: comparison between young and older women. J Nutr (1991) 1.57
Alterations in human intestinal microflora during experimental diarrhoea. Gut (1970) 1.48
The triple threat of aspiration pneumonia. Chest (1975) 1.48
Effect of broad-spectrum parenteral antibiotics on composition of intestinal microflora of humans. Antimicrob Agents Chemother (1987) 1.47
Antibiotics and Clostridium difficile. N Engl J Med (1999) 1.47
Treatment of recurrent Clostridium difficile colitis with Lactobacillus GG. J Pediatr Gastroenterol Nutr (1995) 1.46
Bacteriology and treatment of primary lung abscess. Am Rev Respir Dis (1974) 1.46
National survey on the susceptibility of Bacteroides Fragilis Group: report and analysis of trends for 1997-2000. Clin Infect Dis (2002) 1.46
Intestinal microflora in Asiatic cholera. II. The small bowel. J Infect Dis (1970) 1.46
Isolation of Clostridium in human infections: evaluation of 114 cases. J Infect Dis (1975) 1.46
Safety, tolerance, and pharmacokinetic studies of OPT-80 in healthy volunteers following single and multiple oral doses. Antimicrob Agents Chemother (2008) 1.45
Bacteriology of hospital-acquired pneumonia. Arch Intern Med (1986) 1.45
A randomized comparison of cefoxitin with or without amikacin and clindamycin plus amikacin in surgical sepsis. Ann Surg (1981) 1.45
Favorable experience with bacterial endocarditis in heroin addicts. Ann Intern Med (1973) 1.44
Feasibility of a randomized trial of a low-fat diet for the prevention of breast cancer: dietary compliance in the Women's Health Trial Vanguard Study. Prev Med (1990) 1.43
Effects of time and growth media on short-chain fatty acid production by Bacteroides fragilis. Appl Microbiol (1975) 1.41
Therapeutic efficacy of 29 antimicrobial regimens in experimental intraabdominal sepsis. Rev Infect Dis (1981) 1.40
Alterations in opsonophagocytic killing by neutrophils of Bacteroides fragilis associated with animal and laboratory passage: effect of capsular polysaccharide. J Infect Dis (1982) 1.38
Analysis of trends in antimicrobial resistance patterns among clinical isolates of Bacteroides fragilis group species from 1990 to 1994. Clin Infect Dis (1996) 1.38